{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T03:21:09Z","timestamp":1765423269876,"version":"3.44.0"},"reference-count":116,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T00:00:00Z","timestamp":1666051200000},"content-version":"am","delay-in-days":382,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.bulcan.2021.04.011","type":"journal-article","created":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T18:01:08Z","timestamp":1626976868000},"page":"963-980","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Alop\u00e9cie et cancers\u00a0: de la physiopathologie \u00e0 la pratique clinique"],"prefix":"10.1016","volume":"108","author":[{"given":"Stanislas","family":"Quesada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Guichard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Le Vigouroux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise","family":"Baussard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Fiteni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2008","series-title":"Hair growth and disorders","key":"10.1016\/j.bulcan.2021.04.011_bib0585"},{"issue":"8","key":"10.1016\/j.bulcan.2021.04.011_bib0590","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/exd.14155","article-title":"Hair follicle immune privilege and its collapse in alopecia areata","volume":"29","author":"Bertolini","year":"2020","journal-title":"Exp Dermatol"},{"issue":"1","key":"10.1016\/j.bulcan.2021.04.011_bib0595","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/jdv.13396","article-title":"Evaluation of trichodynia (hair pain) during chemotherapy or tamoxifen treatment in breast cancer patients","volume":"30","author":"Kanti","year":"2016","journal-title":"J Eur Acad Dermatol Venereol JEADV"},{"issue":"3","key":"10.1016\/j.bulcan.2021.04.011_bib0600","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s10549-015-3502-4","article-title":"Quantitative changes in skin composition parameters due to chemotherapy in breast cancer patients: a cohort study","volume":"152","author":"Kang","year":"2015","journal-title":"Breast Cancer Res Treat"},{"issue":"9","key":"10.1016\/j.bulcan.2021.04.011_bib0605","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1001\/jamadermatol.2020.2127","article-title":"Assessment and Treatment Outcomes of Persistent Radiation-Induced Alopecia in Patients With Cancer","volume":"156","author":"Phillips","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"6","key":"10.1016\/j.bulcan.2021.04.011_bib0610","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1001\/jamadermatol.2018.0454","article-title":"Endocrine Therapy-Induced Alopecia in Patients With Breast Cancer","volume":"154","author":"Freites-Martinez","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.bulcan.2021.04.011_bib0615","unstructured":"InfoCancer, ARCAGY-GINECO, traitements, soins de support, la perte des cheveux, alop\u00e9cie, alop\u00e9cie chimio-induite, alop\u00e9cie radio-induite, effets secondaires [Internet]. [Internet]. [cited 2020 29]. Available from: http:\/\/www.arcagy.org\/infocancer\/traitement-du-cancer\/les-soins-de-support\/la-perte-des-cheveux.html\/."},{"issue":"10","key":"10.1016\/j.bulcan.2021.04.011_bib0620","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1634\/theoncologist.2013-0193","article-title":"Alopecia With Endocrine Therapies in Patients With Cancer","volume":"18","author":"Saggar","year":"2013","journal-title":"The Oncologist"},{"issue":"2","key":"10.1016\/j.bulcan.2021.04.011_bib0625","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1440-0960.2012.00946.x","article-title":"Exclamation marks and other trichoscopic signs of chemotherapy-induced alopecia","volume":"54","author":"Pirmez","year":"2013","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.bulcan.2021.04.011_bib0630","series-title":"Hair Trichogram","first-page":"801","article-title":"Agache's measuring the skin: non-invasive investigations, physiology, normal constants","author":"Humbert","year":"2016"},{"key":"10.1016\/j.bulcan.2021.04.011_bib0635","series-title":"The MASCC Textbook of Cancer Supportive Care and Survivorship [Internet]","first-page":"381","article-title":"Chemotherapy-Induced Alopecia: Overview and Methodology for Characterizing Hair Changes and Regrowth","author":"Olsen","year":"2010"},{"issue":"6","key":"10.1016\/j.bulcan.2021.04.011_bib0640","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1001\/jamadermatol.2018.5071","article-title":"Assessment of Quality of Life and Treatment Outcomes of Patients With Persistent Postchemotherapy Alopecia","volume":"155","author":"Freites-Martinez","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"2","key":"10.1016\/j.bulcan.2021.04.011_bib0645","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1016\/S1470-2045(12)70553-3","article-title":"Pathobiology of chemotherapy-induced hair loss","volume":"14","author":"Paus","year":"2013","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.bulcan.2021.04.011_bib0650","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1046\/j.1523-1747.2003.12175.x","article-title":"Molecular mechanisms of chemotherapy-induced hair loss","volume":"8","author":"Botchkarev","year":"2003","journal-title":"J Investig Dermatol Symp Proc"},{"issue":"18","key":"10.1016\/j.bulcan.2021.04.011_bib0655","first-page":"5002","article-title":"p53\u00a0is essential for chemotherapy-induced hair loss","volume":"60","author":"Botchkarev","year":"2000","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.bulcan.2021.04.011_bib0660","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000102025","article-title":"Chemotherapy-Induced Anagen Effluvium: Diffuse or Patterned?","volume":"215","author":"Tr\u00fceb","year":"2007","journal-title":"Dermatology"},{"key":"10.1016\/j.bulcan.2021.04.011_bib0665","series-title":"StatPearls [Internet]","article-title":"Anagen Effluvium","author":"Saleh","year":"2020"},{"issue":"3","key":"10.1016\/j.bulcan.2021.04.011_bib0670","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jaad.2018.04.046","article-title":"Cutaneous toxicity as a predictive biomarker for clinical outcome in patients receiving anticancer therapy","volume":"79","author":"Rzepecki","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.bulcan.2021.04.011_bib0675","doi-asserted-by":"crossref","first-page":"R81","DOI":"10.1186\/bcr3475","article-title":"A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients","volume":"15","author":"Chung","year":"2013","journal-title":"Breast Cancer Res BCR"},{"issue":"5","key":"10.1016\/j.bulcan.2021.04.011_bib0680","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.jaad.2018.03.055","article-title":"Hair disorders in patients with cancer","volume":"80","author":"Freites-Martinez","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.bulcan.2021.04.011_bib0685","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jaad.2009.06.063","article-title":"Permanent chemotherapy-induced alopecia: case report and review of the literature","volume":"63","author":"Tallon","year":"2010","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.bulcan.2021.04.011_bib0690","first-page":"43","article-title":"Busulphan\/cyclophosphamide conditioning for bone marrow transplantation lead to failure of hair regrowth","volume":"7","author":"Baker","year":"1991","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.bulcan.2021.04.011_bib0695","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1046\/j.1440-0960.2000.00405.x","article-title":"Permanent alopecia following chemotherapy and bone marrow transplantation","volume":"41","author":"Tran","year":"2000","journal-title":"Australas J Dermatol"},{"issue":"4","key":"10.1016\/j.bulcan.2021.04.011_bib0700","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1365-2133.2009.09043.x","article-title":"Irreversible and severe alopecia following docetaxel or paclitaxel cytotoxic therapy for breast cancer","volume":"160","author":"Prevezas","year":"2009","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.bulcan.2021.04.011_bib0705","first-page":"2887","article-title":"Permanent chemotherapy-induced alopecia: awareness and attitudes among health care providers","volume":"28","author":"Stoehr","year":"2020","journal-title":"Support Care Cancer Off J Multinatl Assoc Support Care Cancer"},{"issue":"5","key":"10.1016\/j.bulcan.2021.04.011_bib0710","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.jaad.2018.03.056","article-title":"Hair disorders in cancer survivors","volume":"80","author":"Freites-Martinez","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.bulcan.2021.04.011_bib0715","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1634\/theoncologist.2018-0184","article-title":"Permanent Chemotherapy-Induced Alopecia in Patients with Breast Cancer: A 3-Year Prospective Cohort Study","volume":"24","author":"Kang","year":"2019","journal-title":"The Oncologist"},{"issue":"11","key":"10.1016\/j.bulcan.2021.04.011_bib0720","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1093\/annonc\/mds095","article-title":"Permanent scalp alopecia related to breast cancer chemotherapy by sequential fluorouracil\/epirubicin\/cyclophosphamide (FEC) and docetaxel: a prospective study of 20\u00a0patients","volume":"23","author":"Kluger","year":"2012","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"issue":"7","key":"10.1016\/j.bulcan.2021.04.011_bib0725","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/bmt.2017.15","article-title":"Permanent diffuse alopecia after haematopoietic stem cell transplantation in childhood","volume":"52","author":"Bresters","year":"2017","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.bulcan.2021.04.011_bib0730","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jaad.2013.10.034","article-title":"Clinical characteristics of chemotherapy-induced alopecia in childhood","volume":"70","author":"Choi","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"10.1016\/j.bulcan.2021.04.011_bib0735","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1001\/jamadermatol.2020.1867","article-title":"Association Between ABCB1\u00a0Genetic Variants and Persistent Chemotherapy-Induced Alopecia in Women With Breast Cancer","volume":"156","author":"N\u00fa\u00f1ez-Torres","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"4","key":"10.1016\/j.bulcan.2021.04.011_bib0740","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1172\/JCI11317","article-title":"Control of hair growth and follicle size by VEGF-mediated angiogenesis","volume":"107","author":"Yano","year":"2001","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.bulcan.2021.04.011_bib0745","first-page":"1959","article-title":"Genetically null mice reveal a central role for epidermal growth factor receptor in the differentiation of the hair follicle and normal hair development","volume":"150","author":"Hansen","year":"1997","journal-title":"Am J Pathol"},{"issue":"6","key":"10.1016\/j.bulcan.2021.04.011_bib0750","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/j.1474-9726.2009.00526.x","article-title":"Hedgehog signaling maintains hair follicle stem cell phenotype in young and aged human skin","volume":"8","author":"Ritti\u00e9","year":"2009","journal-title":"Aging Cell"},{"issue":"2","key":"10.1016\/j.bulcan.2021.04.011_bib0755","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1053\/j.seminoncol.2012.01.009","article-title":"Advances in the management of cutaneous toxicities of targeted therapies","volume":"39","author":"Robert","year":"2012","journal-title":"Semin Oncol"},{"issue":"Suppl 1","key":"10.1016\/j.bulcan.2021.04.011_bib0760","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s40257-018-0384-3","article-title":"Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails","volume":"19","author":"Lacouture","year":"2018","journal-title":"Am J Clin Dermatol"},{"issue":"12","key":"10.1016\/j.bulcan.2021.04.011_bib0765","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1093\/annonc\/mdv390","article-title":"Alopecia in patients treated with molecularly targeted anticancer therapies","volume":"26","author":"Belum","year":"2015","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"10.1016\/j.bulcan.2021.04.011_bib0770","doi-asserted-by":"crossref","first-page":"734249","DOI":"10.1155\/2014\/734249","article-title":"Epidermal growth factor receptor inhibitors: a review of cutaneous adverse events and management","volume":"2014","author":"Chanprapaph","year":"2014","journal-title":"Dermatol Res Pract"},{"key":"10.1016\/j.bulcan.2021.04.011_bib0775","article-title":"The incidence and risk of cutaneous toxicities associated with dabrafenib in melanoma patients: a systematic review and meta-analysis","author":"Peng","year":"2020","journal-title":"Eur J Hosp Pharm Sci Pract"},{"issue":"4","key":"10.1016\/j.bulcan.2021.04.011_bib0780","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.jaad.2015.01.011","article-title":"RASopathic alopecia: Hair changes associated with vemurafenib therapy","volume":"72","author":"Piraccini","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.bulcan.2021.04.011_bib0785","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.jaad.2018.07.004","article-title":"Efficacy, safety, and comparison of sonic hedgehog inhibitors in basal cell carcinomas: A systematic review and meta-analysis","volume":"79","author":"Xie","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.bulcan.2021.04.011_bib0790","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1111\/bjd.13630","article-title":"Persistent alopecia induced by vismodegib","volume":"172","author":"Alkeraye","year":"2015","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.bulcan.2021.04.011_bib0795","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/annonc\/mds237","article-title":"An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas","volume":"24","author":"Agulnik","year":"2013","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"issue":"3","key":"10.1016\/j.bulcan.2021.04.011_bib0800","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ad.2018.10.019","article-title":"Adverse Hair Reactions to New Targeted Therapies for Cancer","volume":"110","author":"Mir-Bonaf\u00e9","year":"2019","journal-title":"Actas Dermo-Sifiliogr\u00e1ficas Engl Ed"},{"issue":"2","key":"10.1016\/j.bulcan.2021.04.011_bib0805","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s10549-013-2744-2","article-title":"Aromatase inhibitor therapy and hair loss among breast cancer survivors","volume":"142","author":"Gallicchio","year":"2013","journal-title":"Breast Cancer Res Treat"},{"issue":"12","key":"10.1016\/j.bulcan.2021.04.011_bib0810","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.7326\/0003-4819-134-12-200106190-00029","article-title":"Tamoxifen-induced total alopecia","volume":"134","author":"Puglisi","year":"2001","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.bulcan.2021.04.011_bib0815","doi-asserted-by":"crossref","first-page":"469","DOI":"10.5301\/tj.5000376","article-title":"Adjuvant aromatase inhibitor therapy in early breast cancer: what factors lead patients to discontinue treatment?","volume":"101","author":"Moscetti","year":"2015","journal-title":"Tumori"},{"issue":"9","key":"10.1016\/j.bulcan.2021.04.011_bib0820","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1080\/14737140.2017.1355242","article-title":"Fatigue, alopecia and stomatitis among patients with breast cancer receiving cyclin-dependent kinase 4\u00a0and 6\u00a0inhibitors: a systematic review and meta-analysis","volume":"17","author":"Lasheen","year":"2017","journal-title":"Expert Rev Anticancer Ther"},{"issue":"3","key":"10.1016\/j.bulcan.2021.04.011_bib0825","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s10549-017-4523-y","article-title":"Ribociclib with letrozole vs letrozole alone in elderly patients with hormone receptor-positive, HER2-negative breast cancer in the randomized MONALEESA-2\u00a0trial","volume":"167","author":"Sonke","year":"2018","journal-title":"Breast Cancer Res Treat"},{"year":"2019","series-title":"Perez & Brady's principles and practice of radiation oncology","author":"Halperin","key":"10.1016\/j.bulcan.2021.04.011_bib0830"},{"issue":"3","key":"10.1016\/j.bulcan.2021.04.011_bib0835","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.ijrobp.2004.04.031","article-title":"Permanent alopecia after cranial irradiation: Dose\u2013response relationship","volume":"60","author":"Lawenda","year":"2004","journal-title":"Int J Radiat Oncol"},{"issue":"1","key":"10.1016\/j.bulcan.2021.04.011_bib0840","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s13014-014-0220-8","article-title":"Evaluation of permanent alopecia in pediatric medulloblastoma patients treated with proton radiation","volume":"9","author":"Min","year":"2014","journal-title":"Radiat Oncol"},{"issue":"9","key":"10.1016\/j.bulcan.2021.04.011_bib0845","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41571-019-0218-0","article-title":"Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance","volume":"16","author":"Martins","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"10.1016\/j.bulcan.2021.04.011_bib0850","first-page":"86","article-title":"A review of cancer immunotherapy toxicity","volume":"70","author":"Kennedy","year":"2020","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"10.1016\/j.bulcan.2021.04.011_bib0855","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1111\/bjd.15237","article-title":"Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors","volume":"176","author":"Zarbo","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.bulcan.2021.04.011_bib0860","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3389\/fonc.2020.00091","article-title":"Potential Immune-Related Adverse Events Associated With Monotherapy and Combination Therapy of Ipilimumab, Nivolumab, and Pembrolizumab for Advanced Melanoma: A Systematic Review and Meta-Analysis","volume":"10","author":"Almutairi","year":"2020","journal-title":"Front Oncol"},{"issue":"8","key":"10.1016\/j.bulcan.2021.04.011_bib0865","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jdcr.2018.05.022","article-title":"Nivolumab-induced alopecia areata: A reversible factor of good prognosis?","volume":"4","author":"Lakhmiri","year":"2018","journal-title":"JAAD Case Rep"},{"issue":"6","key":"10.1016\/j.bulcan.2021.04.011_bib0870","doi-asserted-by":"crossref","first-page":"NP57","DOI":"10.1177\/0300891619872546","article-title":"Unusual skin toxicity associated with sustained disease response induced by nivolumab in a patient with non-small cell lung cancer","volume":"105","author":"Galli","year":"2019","journal-title":"Tumori"},{"issue":"6","key":"10.1016\/j.bulcan.2021.04.011_bib0875","doi-asserted-by":"crossref","DOI":"10.1111\/dth.14171","article-title":"Alopecia areata as an immune-related adverse event of immune checkpoint inhibitors: A review","volume":"33","author":"Antoury","year":"2020","journal-title":"Dermatol Ther"},{"issue":"11","key":"10.1016\/j.bulcan.2021.04.011_bib0880","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1001\/jamadermatol.2017.2106","article-title":"Hair Repigmentation During Immunotherapy Treatment With an Anti-Programmed Cell Death 1\u00a0and Anti-Programmed Cell Death Ligand 1\u00a0Agent for Lung Cancer","volume":"153","author":"Rivera","year":"2017","journal-title":"JAMA Dermatol"},{"issue":"8","key":"10.1016\/j.bulcan.2021.04.011_bib0885","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1177\/1078155216674355","article-title":"Persistently curly hair phenotype with the use of nivolumab for squamous cell lung cancer","volume":"23","author":"Dasanu","year":"2017","journal-title":"J Oncol Pharm Pract Off Publ Int Soc Oncol Pharm Pract"},{"key":"10.1016\/j.bulcan.2021.04.011_bib0890","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2019.1022","article-title":"Evaluation of Readministration of Immune Checkpoint Inhibitors After Immune-Related Adverse Events in Patients With Cancer","author":"Simonaggio","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.bulcan.2021.04.011_bib0895","first-page":"39","article-title":"The 2016-2019\u00a0ImmunoTOX assessment board report of collaborative management of immune-related adverse events, an observational clinical study","volume":"130","author":"Michot","year":"2020","journal-title":"Eur J Cancer Oxf Engl 1990"},{"issue":"2","key":"10.1016\/j.bulcan.2021.04.011_bib0900","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.bulcan.2019.10.005","article-title":"[Thyroid dysfunctions secondary to cancer immunotherapy]","volume":"107","author":"Cugnet Anceau","year":"2020","journal-title":"Bull Cancer (Paris)"},{"issue":"3","key":"10.1016\/j.bulcan.2021.04.011_bib0905","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s40257-017-0336-3","article-title":"Dermatologic Reactions to Immune Checkpoint Inhibitors: Skin Toxicities and Immunotherapy","volume":"19","author":"Sibaud","year":"2018","journal-title":"Am J Clin Dermatol"},{"issue":"6","key":"10.1016\/j.bulcan.2021.04.011_bib0910","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.clindermatol.2020.06.011","article-title":"Cutaneous immune-related adverse events to checkpoint inhibitors","volume":"38","author":"Malviya","year":"2020","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.bulcan.2021.04.011_bib0915","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.2147\/CMAR.S163391","article-title":"Severe cutaneous adverse reactions induced by targeted anticancer therapies and immunotherapies","volume":"10","author":"Chen","year":"2018","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.bulcan.2021.04.011_bib0920","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2020.594118","article-title":"Sarcoidosis and Cancer: A Complex Relationship","volume":"7","author":"El Jammal","year":"2020","journal-title":"Front Med"},{"issue":"5","key":"10.1016\/j.bulcan.2021.04.011_bib0925","doi-asserted-by":"crossref","first-page":"e13074","DOI":"10.1111\/dth.13074","article-title":"Neutrophilic dermatoses as adverse effects of checkpoint inhibitors: A review","volume":"32","author":"Ravi","year":"2019","journal-title":"Dermatol Ther"},{"issue":"4","key":"10.1016\/j.bulcan.2021.04.011_bib0930","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.nupar.2012.10.002","article-title":"Nutrition chez le patient adulte atteint de cancer: textes courts","volume":"26","author":"Senesse","year":"2012","journal-title":"Nutr Clin M\u00e9tabolisme"},{"key":"10.1016\/j.bulcan.2021.04.011_bib0935","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5826\/dpc.0701a01","article-title":"Diet and hair loss: effects of nutrient deficiency and supplement use","author":"Guo","year":"2017","journal-title":"Dermatol Pract Concept"},{"issue":"5","key":"10.1016\/j.bulcan.2021.04.011_bib0940","doi-asserted-by":"crossref","first-page":"624","DOI":"10.5021\/ad.2014.26.5.624","article-title":"Alopecia Neoplastica due to Gastric Adenocarcinoma Metastasis to the Scalp, Presenting as Alopecia: A Case Report and Literature Review","volume":"26","author":"Kim","year":"2014","journal-title":"Ann Dermatol"},{"issue":"1","key":"10.1016\/j.bulcan.2021.04.011_bib0945","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0190-9622(90)70002-Y","article-title":"Skin involvement as the presenting sign of internal carcinoma","volume":"22","author":"Lookingbill","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.bulcan.2021.04.011_bib0950","first-page":"109","article-title":"Alopecia areata as a paraneoplastic syndrome of gastric cancer","author":"\u00c1lvarez Otero","year":"2016","journal-title":"Rev Esp Enfermedades Dig [Internet]"},{"key":"10.1016\/j.bulcan.2021.04.011_bib0955","article-title":"Alopecia: a common paraneoplastic manifestation of cholangiocarcinoma in humans and animals","author":"Antoniou","year":"2012","journal-title":"Case Rep"},{"issue":"1\u20132","key":"10.1016\/j.bulcan.2021.04.011_bib0960","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jns.2011.05.038","article-title":"Multiple paraneoplastic syndromes: Myasthenia gravis, vitiligo, alopecia areata, and oral lichen planus associated with thymoma","volume":"308","author":"Qiao","year":"2011","journal-title":"J Neurol Sci"},{"issue":"7","key":"10.1016\/j.bulcan.2021.04.011_bib0965","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/jdv.14199","article-title":"Acrokeratosis paraneoplastica (Bazex syndrome) - a systematic review on risk factors, diagnosis, prognosis and management","volume":"31","author":"R\u00e4\u00dfler","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.bulcan.2021.04.011_bib0970","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3325\/cmj.2016.57.229","article-title":"High frequency of cutaneous manifestations including vitiligo and alopecia areata in a prospective cohort of patients with chronic graft-vs-host disease","volume":"57","author":"\u010ceovi\u0107","year":"2016","journal-title":"Croat Med J"},{"issue":"2","key":"10.1016\/j.bulcan.2021.04.011_bib0975","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/annonc\/mdt476","article-title":"Development and validation of Chemotherapy-induced Alopecia Distress Scale (CADS) for breast cancer patients","volume":"25","author":"Cho","year":"2014","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"issue":"12","key":"10.1016\/j.bulcan.2021.04.011_bib0980","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/sj.bjc.6602874","article-title":"Patients\u2019 preferences for adjuvant endocrine therapy in early breast cancer: what makes it worthwhile?","volume":"93","author":"Duric","year":"2005","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.bulcan.2021.04.011_bib0985","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1200\/JCO.2000.18.4.754","article-title":"High-dose sequential chemotherapy with recombinant granulocyte colony-stimulating factor and repeated stem-cell support for inflammatory breast cancer patients: does impact on quality of life jeopardize feasibility and acceptability of treatment?","volume":"18","author":"Macquart-Moulin","year":"2000","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"1","key":"10.1016\/j.bulcan.2021.04.011_bib0990","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/cncr.10630","article-title":"Changing patient perceptions of the side effects of cancer chemotherapy","volume":"95","author":"Carelle","year":"2002","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.bulcan.2021.04.011_bib0995","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1046\/j.1523-5394.1999.07205.x","article-title":"Perception of chemotherapy side effects cancer versus noncancer patients","volume":"7","author":"Lindley","year":"1999","journal-title":"Cancer Pract"},{"issue":"2","key":"10.1016\/j.bulcan.2021.04.011_bib1000","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ejon.2007.10.002","article-title":"The impact of cancer and chemotherapy: perceptual similarities and differences between cancer patients, nurses and physicians","volume":"12","author":"Mulders","year":"2008","journal-title":"Eur J Oncol Nurs Off J Eur Oncol Nurs Soc"},{"issue":"1","key":"10.1016\/j.bulcan.2021.04.011_bib1005","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/15325020490890633","article-title":"Reported experiences of persons with alopecia areata","volume":"10","author":"Hunt","year":"2004","journal-title":"J Loss Trauma"},{"issue":"7522","key":"10.1016\/j.bulcan.2021.04.011_bib1010","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1136\/bmj.331.7522.951","article-title":"The psychological impact of alopecia","volume":"331","author":"Hunt","year":"2005","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.bulcan.2021.04.011_bib1015","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s001050051293","article-title":"[Hairdex: a tool for evaluation of disease-specific quality of life in patients with hair diseases]","volume":"52","author":"Fischer","year":"2001","journal-title":"Hautarzt Z Dermatol Venerol Verwandte Geb"},{"issue":"2","key":"10.1016\/j.bulcan.2021.04.011_bib1020","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.annonc.2019.10.027","article-title":"An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: EORTC QLQ-BR45","volume":"31","author":"Bjelic-Radisic","year":"2020","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"issue":"5","key":"10.1016\/j.bulcan.2021.04.011_bib1025","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1080\/j.1440-1614.2004.01358.x","article-title":"Psychiatric disorder in women with early stage and advanced breast cancer: a comparative analysis","volume":"38","author":"Kissane","year":"2004","journal-title":"Aust N Z J Psychiatry"},{"issue":"2","key":"10.1016\/j.bulcan.2021.04.011_bib1030","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1471-6712.1992.tb00128.x","article-title":"Knowledge, expectations and experiences of patients receiving chemotherapy for breast cancer","volume":"6","author":"Tierney","year":"1992","journal-title":"Scand J Caring Sci"},{"issue":"5","key":"10.1016\/j.bulcan.2021.04.011_bib1035","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1046\/j.1365-2133.2001.04195.x","article-title":"Strategies of coping and quality of life in women with alopecia","volume":"144","author":"Schmidt","year":"2001","journal-title":"Br J Dermatol"},{"issue":"9","key":"10.1016\/j.bulcan.2021.04.011_bib1040","first-page":"2565","article-title":"Efficacy and tolerability of two scalp cooling systems for the prevention of alopecia associated with docetaxel treatment","volume":"21","author":"Betticher","year":"2013","journal-title":"Support Care Cancer Off J Multinatl Assoc Support Care Cancer"},{"issue":"2","key":"10.1016\/j.bulcan.2021.04.011_bib1045","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s10549-011-1453-y","article-title":"Breast cancer scalp metastasis as first metastatic site after scalp cooling: two cases of occurrence after 7- and 9-year follow-up","volume":"128","author":"Lemieux","year":"2011","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.bulcan.2021.04.011_bib1050","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1586\/edm.10.76","article-title":"Presentation, impact and prevention of chemotherapy-induced hair loss: scalp cooling potentials and limitations","volume":"6","author":"Breed","year":"2011","journal-title":"Expert Rev Dermatol"},{"issue":"2","key":"10.1016\/j.bulcan.2021.04.011_bib1055","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1188\/17.CJON.226-233","article-title":"Scalp Cooling: A Literature Review of Efficacy, Safety, and Tolerability for Chemotherapy-Induced Alopecia","volume":"21","author":"Ross","year":"2017","journal-title":"Clin J Oncol Nurs"},{"issue":"6","key":"10.1016\/j.bulcan.2021.04.011_bib1060","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1001\/jama.2016.21038","article-title":"Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer","volume":"317","author":"Rugo","year":"2017","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.bulcan.2021.04.011_bib1065","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1001\/jama.2016.20939","article-title":"Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer: The SCALP Randomized Clinical Trial","volume":"317","author":"Nangia","year":"2017","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.bulcan.2021.04.011_bib1070","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s10549-017-4185-9","article-title":"Scalp cooling with adjuvant\/neoadjuvant chemotherapy for breast cancer and the risk of scalp metastases: systematic review and meta-analysis","volume":"163","author":"Rugo","year":"2017","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.bulcan.2021.04.011_bib1075","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.clbc.2017.07.012","article-title":"Scalp Hypothermia for Preventing Alopecia During Chemotherapy. A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"18","author":"Rugo","year":"2018","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.bulcan.2021.04.011_bib1080","article-title":"Interventions for Preventing Chemotherapy-Induced Alopecia: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials","author":"Zhou","year":"2020","journal-title":"Cancer Nurs"},{"issue":"29","key":"10.1016\/j.bulcan.2021.04.011_bib1085","first-page":"7452","article-title":"Medical Devices\u00a0; General and Plastic Surgery Devices; Classification of the Scalp Cooling System To Reduce the Likelihood of Chemotherapy-Induced Alopecia. Final order","volume":"81","author":"Food and Drug Administration","year":"2016","journal-title":"Fed Regist"},{"issue":"5","key":"10.1016\/j.bulcan.2021.04.011_bib1090","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.abd.2020.03.005","article-title":"Scalp cooling to prevent chemotherapy-induced alopecia","volume":"95","author":"Silva","year":"2020","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.bulcan.2021.04.011_bib1095","article-title":"Prevention and Management of Dermatological Toxicities Related to Anticancer Agents: ESMO Clinical Practice Guidelines\u2020","author":"Lacouture","year":"2020","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.bulcan.2021.04.011_bib1100","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0190-9622(96)90500-9","article-title":"A randomized trial of minoxidil in chemotherapy-induced alopecia","volume":"35","author":"Duvic","year":"1996","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.bulcan.2021.04.011_bib1105","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10549-018-4996-3","article-title":"Safety of 5\u03b1-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies","volume":"174","author":"Rozner","year":"2019","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"10.1016\/j.bulcan.2021.04.011_bib1110","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1080\/13543784.2017.1303480","article-title":"Bimatoprost for the treatment of eyelash, eyebrow and scalp alopecia","volume":"26","author":"Barr\u00f3n-Hern\u00e1ndez","year":"2017","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.bulcan.2021.04.011_bib1115","article-title":"Hair Transplantation in Endocrine Therapy\u2013Induced Alopecia","author":"Bouhanna","year":"2020","journal-title":"Dermatol Surg [Internet]"},{"issue":"5","key":"10.1016\/j.bulcan.2021.04.011_bib1120","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/pbc.20689","article-title":"Surgical interventions for the treatment of radiation-induced alopecia in pediatric practice","volume":"49","author":"Rannan-Eliya","year":"2007","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"10.1016\/j.bulcan.2021.04.011_bib1125","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1634\/theoncologist.2017-0263","article-title":"A Clinical and Biological Guide for Understanding Chemotherapy-Induced Alopecia and Its Prevention","volume":"23","author":"Dunnill","year":"2018","journal-title":"The Oncologist"},{"issue":"1","key":"10.1016\/j.bulcan.2021.04.011_bib1130","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/ijc.28961","article-title":"A new strategy to prevent chemotherapy and radiotherapy-induced alopecia using topically applied vasoconstrictor","volume":"136","author":"Soref","year":"2015","journal-title":"Int J Cancer J Int Cancer"},{"issue":"2","key":"10.1016\/j.bulcan.2021.04.011_bib1135","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0360-3016(92)90750-C","article-title":"Subcutaneous or topical administration of 16,16\u00a0dimethyl prostaglandin E2\u00a0protects from radiation-induced alopecia in mice","volume":"23","author":"Hanson","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"14","key":"10.1016\/j.bulcan.2021.04.011_bib1140","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/j.lfs.2005.09.051","article-title":"The preventive effect of vitamin D3\u00a0on radiation-induced hair toxicity in a rat model","volume":"78","author":"Baltalarli","year":"2006","journal-title":"Life Sci"},{"issue":"12","key":"10.1016\/j.bulcan.2021.04.011_bib1145","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/ijd.13906","article-title":"Pathogenesis and treatment options for chemotherapy-induced alopecia: a systematic review","volume":"57","author":"Rubio-Gonzalez","year":"2018","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.bulcan.2021.04.011_bib1150","unstructured":"Recherche effectu\u00e9e le 26\/11\/2020\u00a0sur la base de donn\u00e9es Clinicaltrials.gov en employant les mots cl\u00e9s \u201ccancer alopecia\u201d [Internet]. [cited 2020 26]. Available from: https:\/\/clinicaltrials.gov\/ct2\/search."},{"issue":"12","key":"10.1016\/j.bulcan.2021.04.011_bib1155","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.5966\/sctm.2015-0397","article-title":"Hair Follicle and Sebaceous Gland Deo Regeneration With Cultured Epidermal Stem Cells and Skin-Derived Precursors: Hair Follicle Regeneration by Cultured Stem Cells","volume":"5","author":"Wang","year":"2016","journal-title":"STEM CELLS Transl Med"},{"issue":"3","key":"10.1016\/j.bulcan.2021.04.011_bib0580","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/sctm.19-0301","article-title":"Tissue engineering strategies for human hair follicle regeneration: How far from a hairy goal?","volume":"9","author":"Castro","year":"2020","journal-title":"STEM CELLS Transl Med"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455121002095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455121002095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T19:34:28Z","timestamp":1757792068000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455121002095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":116,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S0007455121002095"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2021.04.011","relation":{},"ISSN":["0007-4551"],"issn-type":[{"type":"print","value":"0007-4551"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alop\u00e9cie et cancers\u00a0: de la physiopathologie \u00e0 la pratique clinique","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2021.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}